RETIREMENT AGREEMENTRetirement Agreement • February 24th, 2021 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Retirement Agreement (the “Agreement”) by and between W. Michael Kavanaugh, M.D. (“Executive”), and CytomX Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective as of the twenty-fourth day following the date Executive signs this Agreement if not revoked in accordance with Section 5(c)(iii) (the “Effective Date”) with reference to the following facts:
CONSULTING AGREEMENTConsulting Agreement • February 24th, 2021 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Consulting Agreement (the “Agreement”) is made and entered into by and between CytomX Therapeutics, Inc., a Delaware corporation, with an address at 151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080, (“Company”) and Dr. W. Michael Kavanaugh, an individual residing at [***], (“Consultant”), effective as of December 14, 2020 (“Effective Date”).
